跳至主要内容
临床试验/NCT03607812
NCT03607812已完成不适用

ABPM (Automatic Measurement of Blood Pressure) Evaluation in the Diagnosis and Management of Arterial Hypertension for Algerian Patients in Current Medical Practice

Merinal Laboratoires1 个研究点 分布在 1 个国家目标入组 1,027 人开始时间: 2017年6月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,027
试验地点
1
主要终点
Diagnosis of hypertension

研究概览

简要总结

Blood pressure reduction and control are associated with reduced risk of stroke and cardiovascular disease. There is evidence that ambulatory blood pressure monitoring (ABPM) results more accurately reflect the risk of cardiovascular events than do office measurements of blood pressure. New international guidelines recognize the importance of ABPM which has an important and growing role in the diagnosis and in guiding antihypertensive therapy. In 2011 in the United Kingdom, the National Institute for Health and Care Excellence (NICE) recommended that ABPM be performed on all patients with suspected hypertension to confirm the diagnosis and reduce unnecessary treatment in people who do not have true hypertension. The aim of this observational study is to describe the utility of ABPM generally and specifically in the management of hypertension by Cardiologists in the Algerian context.

详细描述

The primary Objective of this study is to assess the benefit of the ABPM in the diagnosis and management of arterial hypertension in by Cardiologists.

The Secondary Objectives are:

  • To identify the conditions of usage of ABPM for the diagnosis of arterial hypertension,
  • To evaluate the blood pressure during the ABPM assessment and at 6 weeks of follow up
  • To describe the study population (socio-demography),
  • To describe the therapeutic stratégies and the compliance to treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who are either hypertensive (defined as those with a clinic SBP ≥ 140 mmHg or DBP ≥ 90 mmHg [7]) or referred for the assessment of hypertension
  • Informed consent obtained before any study-related activity

排除标准

  • ABPM contraindication
  • Patient with psychiatric disorder
  • Patient not able to comply with study-related procedures based on clinical judgement of the investigator

结局指标

主要结局

Diagnosis of hypertension

时间窗: At 24 hours after the inclusion in the study (Visit 2)

Valid 24h-ABPM: blood pressure ≥ 140/90 mmHg

次要结局

  • Patient Demography(At the Inclusion in the study)
  • Therapeutic Decison(At 24 hours after the inclusion in the study (Visit 2))
  • Self-measurement of Arterial blood Pressure(At 6 weeks after the inclusion in the study (Visit 3))
  • Evaluation of Compliance to treatment(At 6 weeks after the inclusion in the study (Visit 3))

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验